The management and disposal of the waste produced in a pharmaceutical manufacturing firm has always been a matter of concern. The waste includes but not limited to in-process wastes, expired products, returned material, manufacturing spillages etc. There has been a…
Recent Post
- CDSCO’s Revised Guidance on Common Submission Format for Import & Registration of Drugs: What Changed in 2026
- DPCO (Amendment) Order, 2026: Overcharging Liability Relief for Pharma manufacturers
- CDSCO Directs Ibuprofen Manufacturers to Add ‘Fixed Drug Eruption’ to PILs
- No Registration Certificate, No Entry for Imported Cosmetics
- CDSCO Clarifies Jurisdiction for Compounding of Offences Applications
